We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.75B
AUM Growth
-$39.4M
Cap. Flow
-$636M
Cap. Flow %
-11.06%
Top 10 Hldgs %
22.09%
Holding
798
New
336
Increased
102
Reduced
128
Closed
170

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$72.3M
2
VYX icon
NCR Voyix
VYX
+$64.1M
3
HUM icon
Humana
HUM
+$64M
4
CNQR
CONCUR TECHNOLOGIES INC
CNQR
+$63.4M
5
TSM icon
TSMC
TSM
+$62.3M

Sector Composition

Rank Sector Weight
1 Healthcare 11.85%
2 Consumer Discretionary 11.63%
3 Consumer Staples 10.69%
4 Industrials 10.3%
5 Technology 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNA icon
551
CareDx
CDNA
$2.39B
$181K ﹤0.01%
+25,000
New +$168K
BEE
552
DELISTED
STRATEGIC HOTELS & RESORTS, INC
BEE
$157K ﹤0.01%
+11,860
New +$149K
CLD
553
DELISTED
Cloud Peak Energy Inc
CLD
$156K ﹤0.01%
+16,955
New +$188K
KG
554
Kestrel Group
KG
$70.6M
$154K ﹤0.01%
+603
New +$149K
LXP icon
555
LXP Industrial Trust
LXP
$3.57B
$150K ﹤0.01%
2,725
-1
-0% -$54
CGRN
556
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$148K ﹤0.01%
1,000
-4,000
-80% -$692K
CBB
557
DELISTED
Cincinnati Bell Inc.
CBB
$142K ﹤0.01%
8,929
+4,011
+82% +$67.9K
NVAX icon
558
Novavax
NVAX
$1.29B
$139K ﹤0.01%
+1,170
New +$122K
CYHHZ
559
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$138K ﹤0.01%
5,006,300
TWO
560
Two Harbors Investment
TWO
$1.27B
$114K ﹤0.01%
+1,426
New +$116K
PVA
561
CALL
DELISTED
PENN VIRGINIA CORP
PVA
$110K ﹤0.01%
+400,000
New +$3.02M
APC
562
CALL
DELISTED
Anadarko Petroleum
APC
$96K ﹤0.01%
+160,800
New +$14M
HYG icon
563
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$71K ﹤0.01%
+145,000
New +$13.2M
KMB icon
564
PUT
Kimberly-Clark
KMB
$36.3B
$50K ﹤0.01%
+251,400
New +$27.9M
FCX icon
565
CALL
Freeport-McMoran
FCX
$97.1B
$48K ﹤0.01%
+302,300
New +$8.34M
TGT icon
566
PUT
Target
TGT
$67.1B
$40K ﹤0.01%
+100,800
New +$6.8M
ORIG
567
PUT
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
$22K ﹤0.01%
+11
New +$1.24M
AKS
568
PUT
DELISTED
AK Steel Holding Corp
AKS
$21K ﹤0.01%
+151,200
New +$951K
NAV
569
PUT
DELISTED
Navistar International
NAV
$20K ﹤0.01%
100,000
WBA
570
PUT
DELISTED
Walgreens Boots Alliance
WBA
$19K ﹤0.01%
+126,000
New +$8.42M
TYC
571
PUT
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$8K ﹤0.01%
+72,198
New +$3.21M
KGC icon
572
CALL
Kinross Gold
KGC
$32.3B
$4K ﹤0.01%
+16,200
New +$45.5K
SQNM
573
CALL
DELISTED
SEQUENOM INC NEW
SQNM
$3K ﹤0.01%
50,000
SPY icon
574
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$2K ﹤0.01%
300,000
-318,000
-51% -$63.9M
MDGL icon
575
CALL
Madrigal Pharmaceuticals
MDGL
$11.9B
$1K ﹤0.01%
714

Similar funds

UBS O'Connor's Q4 2014 Portfolio in Review

As of Q4 2014, UBS O'Connor held 798 positions worth $5.75B, down 0.68% from $5.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

UBS O'Connor withdrew a net $636M in Q4 2014, closing 170 positions and reducing 128 holdings. Its most notable exit was NCR Voyix, an estimated $64.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in CAREFUSION CORPORATION worth $129M.

  • UBS O'Connor's largest Q4 2014 buy was CAREFUSION CORPORATION: 2,168,433 shares worth $129M.
  • UBS O'Connor added most to Allergan Inc in Q4 2014, an estimated $71.6M increase.
  • UBS O'Connor's biggest Q4 2014 reduction was Alibaba, cutting an estimated $72.3M.
  • UBS O'Connor fully exited NCR Voyix in Q4 2014, selling an estimated $64.1M.
  • UBS O'Connor's ten largest holdings make up 22% of its $5.75B portfolio in Q4 2014.
  • UBS O'Connor opened 336 new positions and closed 170 in Q4 2014.
  • UBS O'Connor's portfolio value fell 0.68% quarter-over-quarter to $5.75B.

Based on UBS O'Connor's 13F filing for Q4 2014, filed 13 Feb 2015.